Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan ...( ROCKVILLE Md. Jan. 9 /- Human Genome ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
Date:1/9/2009
ROCKVILLE, Md., Jan. 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that its presentation at the 27th Annual JPMorgan Healthcare Conference will be webcast and may be accessed at www.hgsi.com
(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )
A member of Human Genome Sciences' senior management team will present an overview of the company on Wednesday, January 14, 2009 at 7:30 am Pacific Time (10:30 am Eastern Time).
Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several weeks after the live event.
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.
HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at www.hgsi.com.
'/>"/>
| SOURCE Human Genome Sciences, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
2. HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) Assay Kits and Contract Research Services
3. ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
4. Video: 8-Minute Film Documentary Explores Why Humans Age
5. Scopus to Expand Arts & Humanities Coverage
6. Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
7. Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer
8. Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
9. Human Pheromone Sciences Announces Third Quarter Results
10. Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans
11. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
Post Your Comments:
Breaking Biology Technology:SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance 2SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance 3The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 2The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 3Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 2Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 3Boost for Prostate Cancer Screening - Report Shows Mortality Reduction as High as 31% 2
[0] SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance[0] The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program[0] Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project[0] Boost for Prostate Cancer Screening - Report Shows Mortality Reduction as High as 31%
Other Biology Technology:NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 2NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 3NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 4Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference 2Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer 2
NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, TexasIkaria(R) to Present at 27th Annual JPMorgan Healthcare ConferenceAegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
Breaking Biology News(10 mins):Study reveals how Arctic food webs affect mercury in polar bears 2Small addition to cancer drug may make big difference 2Small addition to cancer drug may make big difference 3Why King Kong failed to impress 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 1Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 3Child burn injuries down significantly 58836 1Child burn injuries down significantly 58836 2Child burn injuries down significantly 58836 3AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities 14342 1AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities 14342 2
Other Biology News:Children's Hospital Oakland is first pediatric hospital to use 'laboratory-on-a-card' technology 2Researchers discover that gene switches on during development of epilepsy 2Researchers discover that gene switches on during development of epilepsy 3$10 million Simons Foundation gift supports new initiative with Institute for Advanced Study 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |